Mark Barnes and Katherine Wang Lead Pharma Industry Roundtable in Shanghai
Health Care partner Mark Barnes (Boston), and life sciences partner Katherine Wang (Shanghai), along with Rebecca Li, Executive Director of the Multi-Region Clinical Trial (MRCT) Center at Harvard, led a pharma industry roundtable in Shanghai on June 2. The roundtable brought together senior regulatory affairs leaders and counsel from multinational pharmaceutical companies to discuss: scientific perspectives on the interpretation of China’s guidance on international multi-country clinical trials (IMCT), how ICH-E-5 and ICH-E17 considerations fit into the regulatory framework relating to multi-regional clinical trials (MRCT), and other scientific issues. The event was very well received, with attendees from leading pharmaceutical companies including GSK, Novartis, Roche, Johnson & Johnson, Pfizer, Boehringer Ingelheim, and Eli Lilly Asia.
